ArticlePloS one2025
Utilization of tetanus and diphtheria serology tests in Alberta, Canada: Patterns and implications.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTetanus and diphtheria (Td) antibody titers can be measured to assess for seroprotection from immunization, though this is not routinely indicated. There are limited population level data on the utilization of these tests and their results.
methodsThis is a population level retrospective study based on laboratory data collected from patients who underwent Td antibody testing. Td IgG titer requests from May 1, 2023, to December 31, 2024, were extracted from the provincial health information system of Alberta, Canada. Td anti-toxin test requests, geometric mean titers, and vaccination status of patients who underwent testing were analyzed. Individuals with multiple tests were assessed for changes in antibody levels, and the proportion of tested individuals who were vaccinated within the past 10 years was calculated. Geometric mean titers were interpreted in relation to established thresholds for long-term protective immunity.
resultsA total of 2,550 patients underwent testing for tetanus (n = 2,349) and diphtheria (n = 2,093) anti-toxin antibody levels. Geometric mean titers varied widely across physician specialties, with pediatrics and Immunology showing higher proportions of recent vaccinations and higher geometric mean titers, while general practice and nephrology had lower values. Nearly 40% of diphtheria test orders in patients immunized within the past 10 years were requested by general practice (n = 336). In contrast, less than 20% of tests were ordered by nephrology (n = 153), pediatrics (n = 95), and pharmacy (n = 12).
conclusionOver half the tests were requested by general practice. Our study highlighted variability in vaccination patterns and immune responses across specialties. While antibody testing is useful for assessing protection, a considerable number of tests were performed in individuals likely to be protected by recent vaccination, pointing to inefficiencies and unnecessary healthcare spending. These findings underscore the importance of aligning test ordering practices with immunization history to optimize resource use, avoid redundant testing, support diagnostic stewardship, and inform more cost-effective public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.